TAS
VIR icon

TIFF Advisory Services’s Vir Biotechnology VIR Stock Holding History

TIFF Advisory Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-831
Closed -$19K – 21
2022
Q3 		$19K Hold
831
– – 0.01% 22
2022
Q2 		$20K Buy
+831
New +$19.4K 0.01% 22

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIFF Advisory Services's VIR Position: Q4 2022 in Review

TIFF Advisory Services sold out of Vir Biotechnology (VIR) in Q4 2022, closing a stake of 831 shares — an estimated $19K sold.

TIFF Advisory Services first reported a position in VIR in Q2 2022 and held it in 2 quarters. The position peaked at $20K in Q2 2022. 224 funds tracked by Wall St. Rank hold VIR as of Q4 2022.

  • TIFF Advisory Services reported no remaining Vir Biotechnology position as of Q4 2022 after selling out during the quarter.
  • TIFF Advisory Services sold 831 Vir Biotechnology shares in Q4 2022, an estimated $19K.
  • TIFF Advisory Services first reported a position in Vir Biotechnology in Q2 2022 and held it in 2 quarters.
  • TIFF Advisory Services's Vir Biotechnology position peaked at $20K in Q2 2022.
  • 224 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2022.

Based on TIFF Advisory Services's 13F filing for Q4 2022, filed 9 Feb 2023.